课题基金 / 基金详情

FIBLAST TRAFERMIN IN TREATMENT OF INTERMITTENT CLAUDICATION

FIBLAST TRAFERMIN IN TREATMENT OF INTERMITTENT CLAUDICATION
FIBLAST TRAFERMIN 治疗间歇性跛行
批准号：
6121117
负责人：
SAMUEL WARD CASSCELLS
金额：
$1.51万
依托单位：
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/6121117
关键词：
body movement cardiovascular disorder chemotherapy claudication clinical research exercise fibroblast growth factor functional ability human subject human therapy evaluation ischemia limbs

项目摘要

项目成果

SAMUEL WARD CASSCELLS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patients with intermittent claudication experience muscle aching or cramping during activity secondary to ischemia. The aim of this study is to determine if basic Fibroblast Growth Factor is effective in safely treating these patients. It will determine whether bFGF can increase blood flow in a sustained fashion due to an increase in vascular supply via new capillary formation and increased collateral flow. Parameters to be tested include exercise performance, functional status, improvement of hyperemic calf flow, and lower limb blood flow.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FIBLAST TRAFERMIN IN TREATMENT OF INTERMITTENT CLAUDICATION
MOLECULAR ATHERECTOMY USING FGF RECEPTORS
MOLECULAR ATHERECTOMY USING FGF RECEPTORS
MOLECULAR ATHERECTOMY USING FGF RECEPTORS